Company Name or Ticker Symbol
Search for other Categories

Cytomx Therapeutics, Inc.  (CTMX)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

CTMX's Revenue Year on Year Growth by Quarter and Year

Cytomx Therapeutics,'s Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
CTMX Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 6.27 -1.94 0.00
III Quarter September - 3.45 1.94 0.00
II Quarter June - 3.09 0.00 0.00
I Quarter March 11.65 2.22 0.00 0.00
FY   11.65 15.03 - -

Financial Statements
Cytomx Therapeutics,'s first quarter 2017 Revenue $ 11.65 millions CTMX's Income Statement
Cytomx Therapeutics,'s first quarter 2016 Revenue $ 2.22 millions Quarterly CTMX's Income Statement
CTMX's Growth by Division See CTMX's Growth by Segment

CTMX Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - 77.84 % - -
II Quarter June - - - -
I Quarter March 424.91 % - - -
FY   - - - -

CTMX Revenue Growth Comment
Cytomx Therapeutics, Inc. achieved in the first quarter, above Company average Revenue surge of 424.91% year on year, to $ 11.65 millions.

Looking into first quarter results within Biotechnology & Drugs industry 3 other companies have achieved higher Revenue growth. While Cytomx Therapeutics, Inc.' s Revenue doubling of 424.91% ranks overall at the positon no. 73 in the first quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #4
Healthcare Sector #20
S&P 500 #73
Revenue Y/Y Growth Statistics
High Average Low
424.2 % 251.17 % 78.13 %
(Mar 31 2017)   (Sep 30 2016)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CTMX's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CTMX's Competitors
Revenue Growth for Cytomx Therapeutics,'s Suppliers
Revenue Growth for CTMX's Customers

You may also want to know
CTMX's Annual Growth Rates CTMX's Profitability Ratios CTMX's Asset Turnover Ratio CTMX's Dividend Growth
CTMX's Roe CTMX's Valuation Ratios CTMX's Financial Strength Ratios CTMX's Dividend Payout Ratio
CTMX's Roa CTMX's Inventory Turnover Ratio CTMX's Growth Rates CTMX's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Biocept Inc  660.30 %$ 660.298 millions
Geovax Labs, Inc.  521.29 %$ 521.292 millions
Cytomx Therapeutics, Inc.  424.20 %$ 424.202 millions
Sientra, Inc.  409.11 %$ 409.109 millions
Sorrento Therapeutics, Inc.  393.32 %$ 393.320 millions
Bluebird Bio, Inc.  355.77 %$ 355.771 millions
Agenus Inc  352.36 %$ 352.365 millions
Protalix Biotherapeutics, Inc.  325.48 %$ 325.479 millions
Lifestyle Medical Network, Inc.  319.44 %$ 319.438 millions
Orexigen Therapeutics, Inc.  280.39 %$ 280.389 millions
Intellia Therapeutics, Inc.  249.75 %$ 249.747 millions
Biolargo, Inc.  230.06 %$ 230.060 millions
Corbus Pharmaceuticals Holdings, Inc.  226.20 %$ 226.199 millions
Exact Sciences Corp  226.01 %$ 226.006 millions
Accelerate Diagnostics, Inc.  225.15 %$ 225.153 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
KWBT's Profile
Stock Price
KWBT's Financials
KWBT's Expectations
Business Description
Charts & Quotes
KWBT's News
KWBT's Competitors
Customers & Markets
Economic Indicators
KWBT's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com